Paloma Partners’s Nuvalent NUVL Stock Holding History

Paloma Partners’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,521	Closed	-$955K	–	108
2025 Q2	$955K	Buy	+12,521	New	+$916K	0.14%	77

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paloma Partners's NUVL Position: Q3 2025 in Review

Paloma Partners sold out of Nuvalent (NUVL) in Q3 2025, closing a stake of 12,521 shares — an estimated $955K sold.

Paloma Partners first reported a position in NUVL in Q2 2025 and held it in 1 quarter. The position peaked at $955K in Q2 2025. 196 funds tracked by Wall St. Rank hold NUVL as of Q3 2025.

Paloma Partners reported no remaining Nuvalent position as of Q3 2025 after selling out during the quarter.
Paloma Partners sold 12,521 Nuvalent shares in Q3 2025, an estimated $955K.
Paloma Partners first reported a position in Nuvalent in Q2 2025 and held it in 1 quarter.
Paloma Partners's Nuvalent position peaked at $955K in Q2 2025.
196 funds tracked by Wall St. Rank held Nuvalent as of Q3 2025.

Based on Paloma Partners's 13F filing for Q3 2025, filed 14 Nov 2025.